Sophion webinar recording: Advancing Cardiac Drug Discovery Together: High-Throughput 3D Contractility with Ethica M and iCell® Cardiomyocytes
Last week, guest speaker Ravi Vaidyanathan from FUJIFILM Cellular Dynamics together with Sophion’s Ozhathil Lijo Cherian and hosted by Sophion’s Damian Bell, led a webinar presenting how combining iPSC-derived cardiac cells (iCell® products) with Ethica M (an automated, high-throughput 3D contractility solution) enable reproducible, scalable, and translational cardiac data.
FUJIFILM Cellular Dynamics introduced their iCell® cardiac portfolio — including human iPSC-derived cardiomyocytes and cardiac fibroblasts — the industry’s benchmark for physiologically relevant and reproducible cardiac models. In the webinar you learn how advanced co-culture systems enable more accurate replication of cardiac function and disease phenotypes.
Sophion showcased Ethica M, an automated high-throughput 3D contractility platform designed to generate and analyze engineered heart tissues at scale. By automating every step of the workflow — from cell-gel mixing to tissue pacing and data analysis — Ethica M delivers human-relevant functional readouts with unmatched efficiency and reproducibility.
Together, iCell® cardiac products and Ethica M create a powerful synergy: predictive, scalable, and reproducible cardiac models that support safer, more effective drug discovery and preclinical development.